Pleckstrin homology (PH) domains and phosphoinositides
- PMID: 17233582
- PMCID: PMC3777418
- DOI: 10.1042/BSS0740081
Pleckstrin homology (PH) domains and phosphoinositides
Abstract
PH (pleckstrin homology) domains represent the 11th most common domain in the human proteome. They are best known for their ability to bind phosphoinositides with high affinity and specificity, although it is now clear that less than 10% of all PH domains share this property. Cases in which PH domains bind specific phosphoinositides with high affinity are restricted to those phosphoinositides that have a pair of adjacent phosphates in their inositol headgroup. Those that do not [PtdIns3P, PtdIns5P and PtdIns(3,5)P2] are instead recognized by distinct classes of domains including FYVE domains, PX (phox homology) domains, PHD (plant homeodomain) fingers and the recently identified PROPPINs (b-propellers that bind polyphosphoinositides). Of the 90% of PH domains that do not bind strongly and specifically to phosphoinositides, few are well understood. One group of PH domains appears to bind both phosphoinositides (with little specificity) and Arf (ADP-ribosylation factor) family small G-proteins, and are targeted to the Golgi apparatus where both phosphoinositides and the relevant Arfs are both present. Here, the PH domains may function as coincidence detectors. A central challenge in understanding the majority of PH domains is to establish whether the very low affinity phosphoinositide binding reported in many cases has any functional relevance. For PH domains from dynamin and from Dbl family proteins, this weak binding does appear to be functionally important, although its precise mechanistic role is unclear. In many other cases, it is quite likely that alternative binding partners are more relevant, and that the observed PH domain homology represents conservation of structural fold rather than function.
Figures


Similar articles
-
Phosphoinositide recognition domains.Traffic. 2003 Apr;4(4):201-13. doi: 10.1034/j.1600-0854.2004.00071.x. Traffic. 2003. PMID: 12694559 Review.
-
Specificity and promiscuity in phosphoinositide binding by pleckstrin homology domains.J Biol Chem. 1998 Nov 13;273(46):30497-508. doi: 10.1074/jbc.273.46.30497. J Biol Chem. 1998. PMID: 9804818
-
The Phox homology (PX) domain, a new player in phosphoinositide signalling.Biochem J. 2001 Dec 15;360(Pt 3):513-30. doi: 10.1042/0264-6021:3600513. Biochem J. 2001. PMID: 11736640 Free PMC article. Review.
-
Classification of the human phox homology (PX) domains based on their phosphoinositide binding specificities.Nat Commun. 2019 Apr 4;10(1):1528. doi: 10.1038/s41467-019-09355-y. Nat Commun. 2019. PMID: 30948714 Free PMC article.
-
Pleckstrin homology domains: not just for phosphoinositides.Biochem Soc Trans. 2004 Nov;32(Pt 5):707-11. doi: 10.1042/BST0320707. Biochem Soc Trans. 2004. PMID: 15493994 Review.
Cited by
-
Crystallization and preliminary X-ray crystallographic analysis of the human CKIP-1 pleckstrin homology domain.Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Mar 1;69(Pt 3):324-7. doi: 10.1107/S1744309113003382. Epub 2013 Feb 27. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013. PMID: 23519814 Free PMC article.
-
Plant actin-binding protein SCAB1 is dimeric actin cross-linker with atypical pleckstrin homology domain.J Biol Chem. 2012 Apr 6;287(15):11981-90. doi: 10.1074/jbc.M111.338525. Epub 2012 Feb 22. J Biol Chem. 2012. PMID: 22356912 Free PMC article.
-
Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation.Elife. 2018 Jul 25;7:e38089. doi: 10.7554/eLife.38089. Elife. 2018. PMID: 30044226 Free PMC article.
-
A pan-apicomplexan phosphoinositide-binding protein acts in malarial microneme exocytosis.EMBO Rep. 2019 Jun;20(6):e47102. doi: 10.15252/embr.201847102. Epub 2019 May 16. EMBO Rep. 2019. PMID: 31097469 Free PMC article.
-
Naomaitai Ameliorated Brain Damage in Rats with Vascular Dementia by PI3K/PDK1/AKT Signaling Pathway.Evid Based Complement Alternat Med. 2019 Feb 5;2019:2702068. doi: 10.1155/2019/2702068. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 30867669 Free PMC article.
References
-
- Haslam RJ, Koide HB, Hemmings BA. Nature. 1993;363:309–310. - PubMed
-
- Mayer BJ, Ren R, Clark KL, Baltimore D. Cell. 1993;73:629–630. - PubMed
-
- Tyers M, Rachubinski RA, Stewart MI, Varrichio AM, Shorr RGL, Haslam RJ, Harley CB. Nature. 1988;333:470–473. - PubMed
-
- Yoon HS, Hajduk PJ, Petros AM, Olejniczak ET, Meadows RP, Fesik SW. Nature. 1994;369:672–675. - PubMed
-
- Macias MJ, Musacchio A, Ponstingl H, Nilges M, Saraste M, Oschkinat H. Nature. 1994;369:675–677. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources